Professional network for doctors with telemedicine and planning tools.
2019: 85,7m | 2020: 116,4m | 35,8%
2020: 116,4m | 2021: 206,9m | 77,8%
Accelerating revenue growth.
0.7 debt / equity, at a rate of less than 2
Score for 2 of the year.
Shares in circulation.: 178,21m
Annual growth: 55,4%
Costs based on calculations
Annual growth: 41,9%
Excellent Unit Economics, revenue grows faster than expenses.
Further, taking into account the growth rate, we calculate 10 years of average annual growth and 10 years of terminal stage by 4%. Profit is reduced according to the rules for calculating discounted cash flows every year by 14,54 %, as it will be easier to invest in the index, rather than taking risks with this startup.
Fair price per share $159.
IPO range: $20 -23.
I am participating.